ClinicalTrials.Veeva

Menu

Dexmedetomidine Reduces Emergence Delirium in Children Undergoing Tonsillectomy With Propofol Anesthesia

A

Athens General Children's Hospital "Pan. & Aglaia Kyriakou"

Status and phase

Completed
Phase 3
Phase 2

Conditions

Postoperative Analgesia
Extubation Time
Emergence Delirium
Heart Rate
Blood Pressure

Treatments

Drug: Normal saline
Device: Bispectral index
Device: Train of four ratio
Drug: Dexmedetomidine

Study type

Interventional

Funder types

Other

Identifiers

NCT03131375
Dexmedetomidine.1.2017

Details and patient eligibility

About

Dexmedetomidine (DEX) is safe and effective in reducing ED following sevoflurane anesthesia. The investigators intend to study the efficacy of DEX in reducing ED in children undergoing tonsillectomy with and without adenoidectomy using total intravenous anesthesia (TIVA) with propofol .

Enrollment

60 patients

Sex

All

Ages

3 to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children
  • ASA I or II
  • tonsillectomy with or without adenoidectomy

Exclusion criteria

  • Allergy to dexmedetomidine
  • Allergy to anesthetic drugs
  • History of neurological disease
  • History of neuromuscular disease
  • History of renal disease
  • History of hepatic disease
  • craniofacial anomalies
  • History of cardiac disease
  • History of respiratory disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

Group A
Active Comparator group
Description:
In Group A: Anesthesia induction drugs: propofol , fentanyl , rocuronium iv. After induction, Group A receives a 50 ml NS infusion containing the drug Dexmedetomidine 1 mcg kg-1 slowly. Anesthesia maintainance drugs: propofol and remifentanil. Reversal of neuromuscular block drugs: Sugammadex according to TOF measurements. Postoperative analgesia drugs: nalbuphine 0.16 mg kg-1 . Monitoring devices: ECG, NIBP , ETCO2, SpO2, Bispectral index, Train of four ratio.
Treatment:
Drug: Dexmedetomidine
Device: Train of four ratio
Device: Bispectral index
Group B
Placebo Comparator group
Description:
In Group B: Anesthesia induction drugs: propofol , fentanyl , rocuronium iv. After induction, Group B receives a volume matched normal saline infusion slowly. Anesthesia maintainance drugs: propofol and remifentanil. Reversal of neuromuscular block drugs: Sugammadex according to TOF measurements. Postoperative analgesia drugs: nalbuphine 0.2 mg kg-1 . Monitoring devices: ECG, NIBP , ETCO2, SpO2, Bispectral index, Train of four ratio.
Treatment:
Device: Train of four ratio
Device: Bispectral index
Drug: Normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems